Korea Investment Partners
Established in 1986, Korea Investment Partners is a prominent venture capital firm headquartered in Seoul. With over three decades of experience, the company invests globally in innovative startups across various sectors, including technology, healthcare, and manufacturing. Notable investments include Kakao, Naver, YG Entertainment, and Didi Chuxing. The firm manages multiple funds with total assets under management exceeding US$1.8 billion.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Dietary Supplements
My Herb & Healthcare
Series A in 2025
MyHerb Healthcare proivdes a specialized analysis for nutritional supplements.
Brave Company
Series A in 2024
Brave Company is a wellness enterprise that develops and markets consumer health brands, focusing on convenient, nutritious products like chicken breast and diet foods. Their mission is to transform daily health habits by integrating their offerings into everyday routines, such as exercise, meals, and social activities. They achieve this by supporting and collaborating with creators through a platform that provides brand incubation, marketing support, personalized recommendations, performance analytics, and offline fitness facilities.
Dr.Diary
Series B in 2022
Founded in 2017, Dr.Diary is a South Korean company specializing in diabetes management solutions. Its flagship application helps users monitor blood sugar levels, track exercise routines and food intake, receive personalized health insights, and communicate with healthcare professionals.
Genome
Series B in 2018
Genome & Company, headquartered in Seongnam, South Korea, specializes in researching microbes and probiotics to develop dietary supplements, cosmeceuticals, and novel drugs targeting conditions such as obesity, diabetes, acne, atopic dermatitis, and cancer-related therapies.
Genome
Series A in 2017
Genome & Company, headquartered in Seongnam, South Korea, specializes in researching microbes and probiotics to develop dietary supplements, cosmeceuticals, and novel drugs targeting conditions such as obesity, diabetes, acne, atopic dermatitis, and cancer-related therapies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.